Are targeted prostate biopsies ready to replace systematic prostate biopsies?

Meng, 2016, Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes, Eur Urol, 69, 512, 10.1016/j.eururo.2015.06.005

Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084

Ahallal, 2016, Rendimiento clínico de biopsia de mapeo guiada por plantilla transperineal para la toma de decisiones terapéuticas en el cáncer de próstata de bajo riesgo, Actas Urol Esp, 40, 615, 10.1016/j.acuro.2016.05.002

Wegelin, 2017, Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: A systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?, Eur Urol, 71, 517, 10.1016/j.eururo.2016.07.041

Bjurlin, 2014, Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assesment, J Urol, 192, 648, 10.1016/j.juro.2014.03.117

Wysock, 2016, Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results, BJU Int, 118, 515, 10.1111/bju.13427

Imaging, 2015

Siddiqui, 2015, Comparison of MR / Ultrasound Fusion – Guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942

D’Amico, 2002, Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era, Cancer, 95, 281, 10.1002/cncr.10657

Albertsen, 1998, Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer, JAMA, 280, 975, 10.1001/jama.280.11.975

Wysock, 2014, A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The profus trial, Eur Urol, 66, 343, 10.1016/j.eururo.2013.10.048

Russo, 2016, Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard, BJU Int, 118, 84, 10.1111/bju.13234

Villers, 2006, Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings, J Urol, 176, 2432, 10.1016/j.juro.2006.08.007

Busby, 2017, Bias in radiology: The how and why of misses and misinterpretations, RadioGraphics, 170107

Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1